2.21
前日終値:
$2.30
開ける:
$2.19
24時間の取引高:
122.99K
Relative Volume:
0.51
時価総額:
$115.57M
収益:
$14.18M
当期純損益:
$-82.66M
株価収益率:
-1.70
EPS:
-1.3
ネットキャッシュフロー:
$-50.80M
1週間 パフォーマンス:
+3.76%
1か月 パフォーマンス:
+4.74%
6か月 パフォーマンス:
-2.21%
1年 パフォーマンス:
+28.49%
Seer Inc Stock (SEER) Company Profile
SEER を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
SEER
Seer Inc
|
2.21 | 135.35M | 14.18M | -82.66M | -50.80M | -1.30 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
638.90 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
289.75 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Seer Inc Stock (SEER) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-07-05 | 再開されました | JP Morgan | Neutral |
2023-01-04 | ダウングレード | BofA Securities | Neutral → Underperform |
2022-08-11 | ダウングレード | JP Morgan | Overweight → Neutral |
2021-10-15 | 再開されました | Cowen | Outperform |
2020-12-29 | 開始されました | BofA Securities | Neutral |
2020-12-29 | 開始されました | Cowen | Outperform |
2020-12-29 | 開始されました | JP Morgan | Overweight |
2020-12-29 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Seer Inc (SEER) 最新ニュース
Seer Inc Inc. (SEER) Price Performance: The Role of Share Buybacks and Stock Splits - investchronicle.com
What high frequency data says about Seer Inc.Trend Confirmation Scanner with Entry Focus - Newser
Why Seer Inc. stock attracts strong analyst attentionFuture Growth Stock Forecasting Strategy - Newser
How to recover losses in Seer Inc. stockFree Weekly Stock Opportunity Radar Scanner - Newser
What data driven models say about Seer Inc.’s futureAI Trading Forecast Based on Big Data - Newser
What makes Seer Inc. stock price move sharplyFree Smart Trade Plans With Risk Protection - Newser
Detecting support and resistance levels for Seer Inc.Free Daily Momentum Screener With Alerts - Newser
Statistical indicators supporting Seer Inc.’s strengthFree High Return Stock Focus With Safety - Newser
Is There Enough Volume to Lift Seer Inc.Accurate Technical Trend Reversal Picks Detected - beatles.ru
Seer Inc. stock chart pattern explainedEarnings Report Summary with Market Impact - Newser
Seer Inc. recovery potential after sell offMomentum Detection with Entry Optimization - Newser
Tick level data insight on Seer Inc. volatilityHigh Probability Trade Plan with Indicators - Newser
Is Seer Inc. in a long term uptrendLow Price High Return Opportunities - kangso.co.kr
Can volume confirm reversal in Seer Inc.AI Powered Stock Market Trend Forecast - Newser
What is Seer Inc. s debt to equity ratioBear Market Strategy Picks - thegnnews.com
Seer, Inc. Earnings Call: Optimism Amid Challenges - The Globe and Mail
How Seer Inc. stock reacts to Fed policy changesPortfolio Safety Metrics and Return Analysis - Newser
Seer, Inc. (NASDAQ:SEER) Q2 2025 Earnings Call Transcript - Insider Monkey
Seer reiterates $17M–$18M revenue target for 2025 amid macro headwinds and new Proteograph ONE launch - MSN
Earnings call transcript: Seer Inc. beats EPS and revenue forecasts in Q2 2025 - Investing.com
Seer (SEER) and the Proteomics Revolution: Is Now the Time to Buy the Dip in a High-Growth Biotech Play? - AInvest
Seer Sees Revenue Target of $17M-$18M for 2025 Amid Macro Challenges and New Product Launch - AInvest
Seer, Inc. Reports Strong Q2 2025 Growth and Innovations - TipRanks
Seer (SEER) Q2 Revenue Jumps 32% - The Motley Fool
Seer (SEER) Q2 Revenue Jumps 32% - Nasdaq
Transcript : Seer, Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Seer, Inc. (SEER) Reports Q2 Loss, Beats Revenue Estimates - sharewise.com
Seer (SEER) Q2 2025 Earnings Call Transcript - AOL.com
Seer's Breakthrough Proteomics Platform: A Defensible Moat in a High-Growth Market - AInvest
Seer Reports 32% YoY Revenue Growth, Launches New Proteograph ONE Assay - AInvest
Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook - GlobeNewswire
Seer Reports Q2 2025 Financials, Reiterates FY 2025 Outlook, Revenue Up 32% YoY - AInvest
Seer Reports 32% Revenue Surge, Unveils Revolutionary High-Throughput Proteomics Platform for Cancer Research - Stock Titan
Seer, Inc. shares fall 1.46% intraday as Chimera Investment reports Q2 earnings. - AInvest
Has Seer Inc. Stock Ever Crashed Historical Volatility ReviewMomentum-Based Prediction for Quick Returns - Newser
Seer Inc. Building a Base Near SupportQuick Gain Stock Watch With Indicators Reviewed - beatles.ru
Is Seer Inc. Stock a Good Fit for Conservative InvestorsBreakout Monitoring with Momentum Analysis - Newser
Fibonacci Support Holding Strong in Seer Inc.Low Risk Swing Trade Opportunities Identified - beatles.ru
What is Seer Inc. company’s growth strategyBreakneck growth rates - Jammu Links News
Is Seer Inc. a growth stock or a value stockTremendous growth opportunities - Jammu Links News
Is it the right time to buy Seer Inc. stockCapitalize on high-yield stocks early - Jammu Links News
How strong is SEER company’s balance sheetMarket-beating performance - Jammu Links News
What catalysts could drive Seer Inc. stock higher in 2025Get exclusive access to premium stock research - Jammu Links News
What institutional investors are buying Seer Inc. stockFree Market Volatility Navigation Tips - Jammu Links News
What analysts say about Seer Inc. stockGet expert analysis on top stock picks - Jammu Links News
Seer Inc (SEER) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):